Preliminary report regarding the use of selective sorbents in complex cardiac surgery patients with extensive sepsis and prolonged intensive care stay

Blood Purification

Volumn 28, Issue 3, 2009, Pages 227-233

  Yaroustovsky, M ^a   Abramyan, M ^a   Popok, Z ^a   Nazarova, E ^a   Stupchenko, O ^a   Popov, D ^a   Plushch, M ^a   Samsonova, N ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Cardiac surgery; Lipopolysaccharide adsorption; Sepsis

Indexed keywords

ADRENALIN; ANTICOAGULANT AGENT; DOBUTAMINE; DOPAMINE; DROTRECOGIN; ENDOTOXIN; HEPARIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; NORADRENALIN; POLYMYXIN B; PROCALCITONIN;

ACUTE KIDNEY FAILURE; ADSORPTION; ADULT; AGED; ANTICOAGULATION; ARTICLE; BIOCOMPATIBILITY; BLOOD CULTURE; BODY TEMPERATURE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DISEASE SEVERITY; GRAM NEGATIVE SEPSIS; HEART SURGERY; HEART TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTOSIS; MEDICAL INSTRUMENTATION; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEPSIS; SURGICAL PATIENT; TREATMENT OUTCOME;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; LENGTH OF STAY; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RENAL DIALYSIS; SEPSIS;

EID: 68549135271     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000231988     Document Type: Article

References (33)

1. Riedermann NC, Murray H, Kellum JA: Fluid resuscitation and immunomodulation in the critically ill. Nat Med 2003; 9: 517-524.
2. Raghfan M, Guo RF, Ward PA: Novel strategies for the treatment of sepsis; in Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine, 2006, pp 68-75.
3. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
4. Gelphand B, Rudnov V, Procenko D, et al: Sepsis: diagnostic, pathogenesis and intensive therapy (in Russian). Infect Chirurg 2004; 2: 2-17.
5. Brun-Buisson C, Meshaka P, Pinton P, et al: EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30: 580-588.
6. Karlsson S, Varpula M, Ruokonen E, Pettilä V, Parviainen I, Ala-Kokko TI, Kolho E, Rintala EM: Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med 2007; 33: 435-443.
7. Ronco Ñ: Role of adsorption for renal replacement and support in sepsis and multiple organ failure. VI International Conference 'Actual aspects of Extracorporeal Blood Purification in Intensive Care medicine', Mîscow, 2008, pp 11-15.
8. Monti G: PMX use for endotoxemic criti- cally ill patients. Crit Care 2008;12(suppl 2):134.
9. Cole L, Bellomo R, Hart G, et al: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30: 100-106.
10. Ronco C, D'Intini V, Bellomo R, Ricci Z, Bonello M, Ratanarat R, Salvatori G, Bordoni V, Andrikos E, Brendolan A: The rationale for extracorporeal therapies in sepsis (in Russian). Anaest Reanimat 2005; 2: 87-91.
11. Bellomo R, Kellum JA, Ronco C: Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007; 33: 409-413.
12. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effect of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002; 30: 2205-2211.
13. Honore PM, Matson JR: Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care Med 2002; 6: 394-396.
14. Kellum JA: Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin- 10, reduces nuclear factor-B DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32: 801-805.
15. Pierre L, Blomqvist S, Ljunggren L, Steen S: The effects of a novel medical device for reduction of LPS in porcine endotoxemia. V International Conference 'Actual aspects of Extracorporeal Blood Purification in Intensive Care medicine', Mîscow, 2006, pp 31-32.
16. Shoji H: Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003; 7: 108-114.
17. Bellomo R, Ronco C, Kellum JA, Metha RL, Palevsky P: Acute renal failure - definition, outcome measure, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
18. Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, Uchiyama Y, Akizawa T, Takahashi K, Sugai T: Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin- B immobilized column. Artif Organs 1998; 22: 1038-1044.
19. Uriu K, Osajima A, Hiroshige K, et al: Endotoxin removal by direct hemoperfusion with an adsorbent column using polymixin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 2002; 39: 937-947.
20. Uriu K, Osajima A, Kamochi M, Watanabe H, Aibara K, Kaizu K: The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the absorbent column using polymyxin B-immobilized fiber in patients with Gram-negative septic shock. Ther Apher 2001; 5: 25-30.
21. Casella G, Monti G, Terzi V, Pulici M, Ravizza A, Vesconi S: Terapie 'non-convenzionali' nello shock settico refrattario: esperienza clinica con polymyxin B. Minerva Anestesiol 2006; 72(suppl 1):63-67.
22. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Sigeatu Endo S: Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006; 10: 12-18.
23. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K: Early haemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005; 9:R653-R661.
24. Nakamura T, Kawagoe Y, Matsuda T, Shoji H, Ueda Y, Tamura N, Ebihara I, Koide H: Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients. Blood Purif 2004; 22: 256-260.
25. Tojimbara T, Sato S, Nakajima I, et al: Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure. Ther Apher Dial 2004; 8: 286-292.
26. Tsushima K, Kubo K, Koizumi T, Yamamoto H, Fujimoto K, Hora K, Kan-Nou Y: Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher 2002; 17: 97-102.
27. Vincent J, Laterre P, Cohen J, Burchard H, Bruining H, Lerma F, Wittebole X, de Backer D, Brett S, Marzo D, Nakamura H, John S: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005; 23: 400-405.
28. Yaroustovsky MB, Gelfand B, Popok Z, Abramyan M, Nazarova E, Yakovleva I, Popov DA, Plyushtch M: Lipopolysaccharide adsorption in combined therapy of patients with severe sepsis. Crit care 2008; 12(suppl 2):178.
29. Haase M, Bellomo R, Morgera S, Baldwin I, Boyce N: High cut-off point membrane in septic acute renal faiure: a systematic review. Int J Artif Organs 2007; 30: 1031-1041.
30. Tani T, Hanasawa K, Kodama M, et al: Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor- 1 in septic patients. World J Surg 2001; 25: 660-668.
31. Kushi H, Miki T, Nakahara J, Okamoto K, Saito T, Tanjoh K: Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase. Blood Purif 2006; 24: 212-217. (Pubitemid 43259176)
32. Blomquist S, Gustafsson V, Manopolos T, Pierre L: Clinical experience with lipopolysaccharide absorber in cardiac surgery. Crit Care 2007; 11(suppl 4):P43.
33. Cruz DN, Perazella MA, Bellomo R, Polanco N, Massimo de Cal, Corradi V, Nalesso F, Lentini P, Ueno T, Ranieri MV, Ronco C: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007; 11:R47.